Table 2.

Safety and compliance parameters in the study arms

Parameter and Study MomentKD (n=104)LPD (n=103)P Valueb
SGA A, %
 Baseline86900.29
 End of study83820.83
BMI (kg/m2)
 Baseline23.6 (23.1 to 24.2)23.2 (22.7 to 23.7)0.20
 End of study23.3 (22.9 to 23.7)23.1 (22.6 to 23.5)0.45
TSF (cm)
 Baseline20.0 (19.6 to 20.4)19.9 (19.8 to 20.3)0.82
 End of study19.8 (19.3 to 20.1)19.7 (19.5 to 20.1)0.94
MAMC (cm)
 Baseline23.4 (23.1 to 23.6)23.2 (22.9 to 23.4)0.46
 End of study23.1 (22.8 to 23.5)22.8 (22.7 to 23.2)0.26
CRP (mg/L)a
 Baseline4.6 (4.1 to 5.1)4.4 (3.9 to 4.8)0.45
 End of study4.8 (4.3 to 5.4)6.4 (5.7 to 7.0)<0.01
Serum albumin (g/dl)b
 Baseline4.1 (4.1 to 4.2)4.1 (4.1 to 4.2)0.51
 End of study4.1 (4.0 to 4.1)4.1 (4.1 to 4.2)0.65
Serum total cholesterol (mg/dl)
 Baseline225.5 (218.0 to 232.0)217.0 (214.0 to 222.0)0.06
 End of study198.4 (190.8 to 206.0)197.7 (192.0 to 203.4)0.87
Serum potassium (mEq/L)c
 Baseline4.7 (4.4 to 5.0)4.2 (4.1 to 4.4)0.001
 End of study4.9 (4.7 to 5.0)4.6 (4.5 to 4.7)0.12
Protein intake (g/kg per day)
 Baseline0.61 (0.58 to 0.62)0.60 (0.58 to 0.61)0.84
 End of study0.29 (0.29 to 031)0.58 (0.57 to 0.59)<0.01
Energy intake (kcal/kg per day)
 Baseline31.0 (30.2 to 31.6)30.5 (30.0 to 31.0)0.26
 End of study30.5 (29.5 to 31.5)30.2 (29.8 to 30.8)0.99